A new research shows the routine screening and genetic testing of the relatives of patients suffering from aortic diseases could save lives. The study was published in the Journal of the American Heart Association which shows that over 30% of relatives of patients suffering from thoracic aortic diseases (TAD) have an underlying genetic predisposition to developing an aortic disease themselves.
TAD, including aneurysms and dissections, are often silent entities until they become life-threatening emergencies, at which point they have a high chance of mortality approaching 80%. The study, which is part-funded by the British Heart Foundation, highlights the importance of routine imaging and genetic testing of relatives of patients affected by TAD to identify the diseases early.
Patients At Risk
The research also suggests that current guidelines for the condition are likely to result in the under-treatment of patients who are potentially at-risk, particularly as screening is not routinely performed in the UK.
Our research identifies important knowledge gaps concerning the predictive accuracy of commonly used screening tests across patients with thoracic aortic diseases. The evidence suggests that screening of first and second-degree relatives of patients affected by familial non-syndromic thoracic aortic diseases, and first-degree relatives of those affected by sporadic TAD will result in a significant number of patients being diagnosed who would otherwise remain unaware they suffer from the disease, which could potentially save lives.
Traditionally, Aortic Dissection has been regarded by the medical profession as a 'silent killer,' striking mainly the over-65s, with little opportunity for prediction or prevention. Sadly, we know of many patients in the UK and Ireland who died suddenly due to a lack of appropriate screening.
Patients who survive Aortic Dissection say their #1 worry is that close relatives may also be affected by the condition. This research shows that there is a significant cohort of up to 30% of patients, including many younger patients, in whom a genetic predisposition to Aortic Dissection can and should be detected through appropriate screening.
Prevention And Treatment
Prevention is always better than cure. Dr. Mariscalco and his team are to be congratulated on highlighting this issue. They expect that changes to national screening programmes as a result of this research will save lives, by improving the prevention, detection, and treatment of Aortic Dissection.
This study involved a combination of genetic and imaging tests, including echocardiogram, CT-scan, and MRI of the aorta. All of these tests could easily be adopted as simple and quick routine screening tools to identify relatives of patients at risk for aortic diseases.
Now that we have a better idea of the percentage of relatives of people with aortic diseases who are also likely to suffer from the condition we can start to ascertain the financial viability of introducing routine screening for this at-risk group.